Search Within

Andrew D Seidman

  1. "Survivorship Research"
Formats
  1. Journal Article (80)
  2. Meeting Abstract (69)
  3. Conference Paper (7)
  4. Book Section (1)
  5. Editorial (1)
Groups
  1. Breast Medicine Service (158)
  2. Department of Medicine (158)
  3. Solid Tumor Oncology Division (158)
  4. Survivorship Research (158)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (97)
  6. Epidemiology and Biostatistics (62)

More Groups

People
  1. Clifford Hudis (116)
  2. Larry Norton (87)
  3. Teresa Gilewski (38)
  4. Monica Fornier (37)
  5. Gabriella D'Andrea-Carlino (36)
  6. Violante Currie (32)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (2)
  4. 2022 (5)
  5. 2021 (3)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (51)
  2. Breast Cancer Research and Treatment (19)
  3. Cancer Research (12)
  4. Clinical Breast Cancer (11)
  5. Seminars in Oncology (9)
  6. Clinical Cancer Research (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (51)
  2. Elsevier Inc. (29)
  3. Springer (22)
  4. American Association for Cancer Research (21)
  5. Oxford University Press (9)
  6. Informa Healthcare (6)

More Publishers

Results (158)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II trial of nanoparticle albumin-bound paclitaxel in three dosing schedules with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (MBC)
    Meeting Abstract

    Conlin, A. K.; Hudis, C. A.; Bach, A.; Moynahan, M.; Lake, D.; Forero-Torres, A.; Wright, G.; Hackney, M.; Clawson, A.; Seidman, A. D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Uniformly positive (> 80%) HER2 expression maximizes sensitivity and specificity for prediction of response to trastuzumab in CALGB 9840
    Meeting Abstract

    Rimm, D. L.; Broadwater, G.; Friedman, P.; Berry, D.; Seidman, A.; Hudis, C.; Winer, E.; Harris, L.; Thor, A.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
    Meeting Abstract

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: Immunological effects
    Journal Article

    Deng, G.; Lin, H.; Seidman, A.; Fornier, M.; D'Andrea, G.; Wesa, K.; Yeung, S.; Cunningham Rundles, S.; Vickers, A. J.; Cassileth, B.
    Journal of Cancer Research and Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients
    Meeting Abstract

    Deng, G.; Smith-Jones, H. L.; Seidman, A. D.; Fornier, M.; D'Andrea, G.; Wesa, K.; Cunningham-Rundles, S.; Yeung, K. S.; Vickers, A.; Cassileth, B. R.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II trial of patupilone in patients (pts) with breast cancer brain metastases (BCBM) progressing or recurring after whole brain radiation therapy (WBXRT)
    Meeting Abstract

    Conlin, A. K.; D'Andrea, G.; Hudis, C. A.; Robson, M. E.; Drullinsky, P.; Theodoulou, M.; Lis, E.; Kang, T. Y.; Peereboom, D. M.; Seidman, A. D.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Incidence and severity of sensory neuropathy (SN) with bevacizumab (B) added to dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound (nab) paclitaxel (P) in patients (pts) with early stage breast cancer (BC)
    Meeting Abstract

    Sierecki, M. R.; Rugo, H. S.; McArthur, H. L.; Traina, T. A.; Paulson, M.; Rourke, M.; Norton, L.; Seidman, A. D.; Hudis, C. A.; Dickler, M. N.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Clinical and pathologic correlates in breast cancer (BC) brain metastasis (BM): Tissue microarray (TMA) studies
    Meeting Abstract

    Johnson, M. L.; Nehhozina, T.; Conlin, A. K.; Hsu, M.; Patil, S.; Jhaveri, K.; Hudis, C. A.; Brogi, E.; Seidman, A. D.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II study of weekly nanoparticle albumin bound (nab)paclitaxel with carboplatin and trastuzumab as 1st-line therapy for HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Seidman, A. D.; Conlin, A. K.; Bach, A.; Brufsky, A. M.; Saleh, M. N.; Lake, D.; Dickler, M. N.; D'Andrea, G.; Traina, T. A.; Hudis, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Preliminary safety results of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2 overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C. T.; Lin, N. U.; Lake, D.; Dickler, M. N.; Modi, S.; Seidman, A. D.; Steingart, R. M.; Norton, L.; Winer, E. P.; Hudis, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save